Profile data is unavailable for this security.
About the company
Ortivus AB is a Sweden-based provider of mobile solutions for modern emergency medical services. The Company is engaged in the development of mobile surveillance and communication solutions, forming a decision support system. Its offering comprises: MobiMed Smart, a decision support system, which allows ambulance personnel to handle documentation, monitoring and introduce a structured approach in prehospital care; CoroNet, a mobile surveillance solution which allows patients to move freely under supervision of medical staff and provides healthcare professionals with monitoring information. In addition, the Company provides a wide range of services, such as support, implementation, training and consulting, among others. The Company’s customer base includes mainly ambulance services and emergency departments.
- Revenue in SEK (TTM)73.40m
- Net income in SEK-21.88m
- Incorporated1985
- Employees38.00
- LocationOrtivus ABSvardvagen 19DANDERYD 182 33SwedenSWE
- Phone+46 84464500
- Fax+46 84464519
- Websitehttps://www.ortivus.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scandinavian ChemoTech AB | 12.29m | -8.06m | 83.55m | 1.00 | -- | 28.04 | -- | 6.80 | -0.3362 | -0.3362 | 0.5146 | 0.1252 | 0.9244 | 0.6518 | 6.25 | 12,285,000.00 | -60.62 | -92.25 | -175.78 | -136.29 | 83.81 | 88.02 | -65.58 | -375.55 | 0.6335 | -4.06 | -- | -- | 87.10 | 147.98 | 41.27 | -- | -- | -- |
| SyntheticMR AB (publ) | 57.05m | -54.93m | 88.44m | 41.00 | -- | 0.5993 | -- | 1.55 | -0.9057 | -0.9057 | 0.9467 | 1.65 | 0.3678 | -- | 0.8733 | 1,391,415.00 | -35.42 | -7.92 | -51.34 | -10.51 | 10.41 | 56.07 | -96.28 | -14.37 | -- | -8.73 | 0.0450 | -- | 2.47 | 3.20 | -241.50 | -- | 7.37 | -- |
| Bioretec Oy | 37.44m | -92.34m | 89.66m | 60.00 | -- | 0.861 | -- | 2.39 | -0.29 | -0.29 | 0.1177 | 0.3171 | 0.3032 | 0.5513 | 2.23 | 58,500.00 | -74.77 | -62.68 | -86.25 | -80.54 | 57.61 | 69.60 | -246.61 | -155.57 | 2.99 | -6.57 | 0.0139 | -- | -22.48 | 18.63 | -105.54 | -- | -- | -- |
| Iconovo AB | 1.11m | -43.36m | 110.60m | 13.00 | -- | 0.5175 | -- | 100.09 | -1.31 | -1.31 | 0.0287 | 2.22 | 0.008 | -- | 2.70 | -- | -31.34 | -31.04 | -34.30 | -34.58 | 1,042.35 | 198.84 | -3,924.34 | -469.09 | -- | -171.76 | 0.0305 | -- | -62.34 | -42.64 | -5.41 | -- | 2.30 | -- |
| Scandinavian Real Heart AB | 0.00 | -38.87m | 118.54m | 12.00 | -- | 0.8356 | -- | -- | -16.17 | -16.17 | 0.00 | 16.69 | 0.00 | -- | -- | 0.00 | -44.53 | -27.49 | -52.77 | -30.65 | -- | -- | -- | -12,518.77 | -- | -- | 0.0678 | -- | -- | -- | 49.47 | -- | 6.59 | -- |
| Arcoma AB | 132.94m | 4.35m | 121.62m | 31.00 | 26.52 | 1.66 | 10.50 | 0.9149 | 0.3205 | 0.3205 | 9.87 | 5.13 | 1.45 | 2.92 | 13.71 | 4,288,452.00 | 4.75 | 2.16 | 6.66 | 3.75 | 40.45 | 37.95 | 3.27 | 1.40 | 2.04 | -- | 0.00 | 0.00 | -3.81 | 3.24 | 336.00 | 11.08 | -9.43 | -- |
| Scandinavian Medical Solutions A/S | 350.40m | 37.12k | 130.21m | 28.00 | 4,969.70 | 1.10 | 10.42 | 0.3716 | 0.0007 | 0.0007 | 8.88 | 2.99 | 1.29 | 1.94 | 11.19 | -- | 0.0137 | 6.59 | 0.0246 | 11.68 | 23.12 | 24.88 | 0.0106 | 4.68 | 0.3524 | 1.14 | 0.4345 | -- | 8.28 | 42.38 | -99.67 | -64.34 | -- | -- |
| Ortivus AB | 73.40m | -21.88m | 133.91m | 38.00 | -- | 6.09 | -- | 1.82 | -0.4318 | -0.4318 | 1.43 | 0.2527 | 1.09 | 7.14 | 10.99 | 1,931,632.00 | -32.45 | -13.20 | -61.44 | -23.30 | 40.33 | 42.36 | -29.80 | -11.43 | 0.8252 | -10.66 | 0.4656 | -- | -8.72 | -7.36 | 12.16 | -- | -- | -- |
| Bactiquant A/S | 11.79m | -18.68m | 140.88m | -- | -- | 9.66 | -- | 11.95 | -0.4696 | -0.4696 | 0.2966 | 0.2723 | 0.4656 | 2.69 | 15.14 | -- | -73.73 | -55.41 | -85.85 | -64.53 | -31.80 | -10.94 | -158.37 | -121.81 | 3.26 | -9.70 | 0.1926 | -- | -41.68 | -14.27 | -4.72 | -- | -- | -- |
| Observe Medical ASA | 15.90m | -117.24m | 142.17m | 4.00 | -- | 5.76 | -- | 8.94 | -26.57 | -26.57 | 3.29 | 0.1909 | 0.1118 | 2.87 | 8.29 | 3,350,800.00 | -82.38 | -42.22 | -205.00 | -64.14 | 6.24 | 30.17 | -737.14 | -327.97 | 0.1175 | -3.72 | 0.9572 | -- | -33.85 | 153.47 | -98.73 | -- | -2.97 | -- |
| Immunovia AB (publ) | 684.00k | -145.91m | 146.31m | 13.00 | -- | 2.26 | -- | 213.90 | -0.4037 | -0.4037 | 0.0017 | 0.0962 | 0.0113 | 732.25 | 35.08 | 52,615.38 | -240.68 | -65.80 | -355.49 | -73.17 | -6,269.74 | -6,349.71 | -21,332.75 | -16,524.19 | 3.42 | -1.23 | 0.0131 | -- | -26.42 | 13.60 | -90.64 | -- | -34.89 | -- |
| iZafe Group AB | 5.99m | -16.68m | 162.75m | 10.00 | -- | 13.95 | -- | 27.17 | -0.0497 | -0.0497 | 0.0178 | 0.0315 | 0.2002 | 4.03 | 8.65 | 599,100.00 | -55.71 | -66.81 | -91.50 | -83.32 | -74.75 | -303.52 | -278.35 | -762.55 | 0.47 | -2,397.57 | 0.0054 | -- | -24.68 | -7.62 | 18.69 | -- | -- | -- |
| Subgen AI AB | 0.00 | -64.18m | 166.22m | 15.00 | -- | -- | -- | -- | -544.10 | -544.10 | 0.00 | -25.11 | 0.00 | -- | -- | 0.00 | -188.83 | -- | -403.12 | -- | -- | -- | -- | -- | -- | -4.46 | -- | -- | -100.00 | -- | 16.86 | -- | -- | -- |
| Boule Diagnostics AB | 489.60m | -3.50m | 166.98m | 187.00 | -- | 0.9963 | 9.94 | 0.3411 | -0.10 | -0.10 | 12.63 | 4.32 | 0.9926 | 4.68 | 3.50 | 2,618,182.00 | -0.7096 | -7.78 | -1.35 | -11.85 | 43.65 | 43.53 | -0.7149 | -9.10 | 0.8039 | 2.96 | 0.5717 | -- | -12.31 | 4.11 | 98.72 | -- | -5.26 | -- |
| Kdventures AB | 1.67m | -193.86m | 177.38m | 8.00 | -- | 0.0856 | -- | 106.15 | -0.5849 | -0.5849 | 0.005 | 3.16 | 0.0015 | -- | 0.4858 | -- | -16.82 | -1.95 | -16.98 | -2.03 | -- | -- | -11,601.14 | -1,139.53 | -- | -0.7754 | 0.0011 | -- | -9.09 | -8.82 | -2,292.98 | -- | -- | -- |
| Micropos Medical AB (publ) | 8.08m | -21.73m | 182.32m | 9.00 | -- | -- | -- | 22.57 | -0.1398 | -0.1398 | 0.0514 | -- | -- | -- | -- | -- | -- | -83.62 | -- | -110.96 | 120.03 | 94.59 | -268.99 | -558.00 | -- | -99.12 | -- | -- | 112.49 | 17.01 | 0.7589 | -- | -16.83 | -- |
Data as of Mar 02 2026. Currency figures normalised to Ortivus AB's reporting currency: Swedish Krona SEK
1.84%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Seligson & Co. Rahastoyhti� Oyjas of 30 Jan 2026 | 1.60m | 1.84% |
| FCG Fonder ABas of 31 Mar 2025 | 6.87k | 0.01% |
Data from 30 Dec 2025 - 30 Jan 2026Source: FactSet Research Systems Inc.
